Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 1
2007 1
2008 2
2009 1
2010 3
2011 3
2012 1
2013 4
2014 1
2015 4
2016 6
2017 10
2018 11
2019 8
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

62 results
Results by year
Filters applied: . Clear all
Page 1
TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group.
Cremolini C, Marmorino F, Loupakis F, Masi G, Antoniotti C, Salvatore L, Schirripa M, Boni L, Zagonel V, Lonardi S, Aprile G, Tamburini E, Ricci V, Ronzoni M, Pietrantonio F, Valsuani C, Tomasello G, Passardi A, Allegrini G, Di Donato S, Santini D, Falcone A; all the investigators of the Gruppo Oncologico del Nord Ovest. Cremolini C, et al. Among authors: passardi a. BMC Cancer. 2017 Jun 9;17(1):408. doi: 10.1186/s12885-017-3360-z. BMC Cancer. 2017. PMID: 28599628 Free PMC article. Clinical Trial.
TRIPLETE: a randomised phase III study of modified FOLFOXIRI plus panitumumab versus mFOLFOX6 plus panitumumab as initial therapy for patients with unresectable RAS and BRAF wild-type metastatic colorectal cancer.
Borelli B, Moretto R, Lonardi S, Bonetti A, Antoniotti C, Pietrantonio F, Masi G, Burgio V, Marmorino F, Salvatore L, Rossini D, Zaniboni A, Zucchelli G, Martignetti A, Di Battista M, Pella N, Passardi A, Boccaccino A, Leone F, Colombo C, Granetto C, Vannini F, Marsico VA, Martinelli E, Antonuzzo L, Vitello S, Delliponti L, Boni L, Cremolini C, Falcone A. Borelli B, et al. Among authors: passardi a. ESMO Open. 2018 Jul 9;3(4):e000403. doi: 10.1136/esmoopen-2018-000403. eCollection 2018. ESMO Open. 2018. PMID: 30018814 Free PMC article.
Heterogeneity in Colorectal Cancer: A Challenge for Personalized Medicine?
Molinari C, Marisi G, Passardi A, Matteucci L, De Maio G, Ulivi P. Molinari C, et al. Among authors: passardi a. Int J Mol Sci. 2018 Nov 23;19(12):3733. doi: 10.3390/ijms19123733. Int J Mol Sci. 2018. PMID: 30477151 Free PMC article. Review.
Immune Checkpoints as a Target for Colorectal Cancer Treatment.
Passardi A, Canale M, Valgiusti M, Ulivi P. Passardi A, et al. Int J Mol Sci. 2017 Jun 21;18(6):1324. doi: 10.3390/ijms18061324. Int J Mol Sci. 2017. PMID: 28635639 Free PMC article. Review.
Clinical and circulating biomarkers of survival and recurrence after radiofrequency ablation in patients with hepatocellular carcinoma.
Canale M, Ulivi P, Foschi FG, Scarpi E, De Matteis S, Donati G, Ercolani G, Scartozzi M, Faloppi L, Passardi A, Tamburini E, Valgiusti M, Marisi G, Frassineti GL, Casadei Gardini A. Canale M, et al. Among authors: passardi a. Crit Rev Oncol Hematol. 2018 Sep;129:44-53. doi: 10.1016/j.critrevonc.2018.06.017. Epub 2018 Jun 23. Crit Rev Oncol Hematol. 2018. PMID: 30097237 Free article. Review.
Special Issue on Basic and Translational Research in Colorectal Cancer.
Ulivi P, Scarpi E, Passardi A. Ulivi P, et al. Among authors: passardi a. Int J Mol Sci. 2019 Jun 25;20(12):3095. doi: 10.3390/ijms20123095. Int J Mol Sci. 2019. PMID: 31242580 Free PMC article.
Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan.
Fornaro L, Leone F, Vienot A, Casadei-Gardini A, Vivaldi C, Lièvre A, Lombardi P, De Luca E, Vernerey D, Sperti E, Musettini G, Satolli MA, Edeline J, Spadi R, Neuzillet C, Falcone A, Pasquini G, Clerico M, Passardi A, Buscaglia P, Meurisse A, Aglietta M, Brac C, Vasile E, Montagnani F. Fornaro L, et al. Among authors: passardi a. Clin Colorectal Cancer. 2019 Dec;18(4):e394-e401. doi: 10.1016/j.clcc.2019.08.004. Epub 2019 Sep 4. Clin Colorectal Cancer. 2019. PMID: 31564556
Preoperative Chemotherapy and Resection Margin Status in Colorectal Liver Metastasis Patients: A Propensity Score-Matched Analysis.
Solaini L, Gardini A, Passardi A, Mirarchi MT, D'Acapito F, La Barba G, Cucchi M, Casadei Gardini A, Frassineti GL, Cucchetti A, Ercolani G. Solaini L, et al. Among authors: passardi a. Am Surg. 2019 May 1;85(5):488-493. Am Surg. 2019. PMID: 31126361 Free article.
Circulating Plasma Levels of miR-20b, miR-29b and miR-155 as Predictors of Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer.
Ulivi P, Canale M, Passardi A, Marisi G, Valgiusti M, Frassineti GL, Calistri D, Amadori D, Scarpi E. Ulivi P, et al. Among authors: passardi a. Int J Mol Sci. 2018 Jan 20;19(1):307. doi: 10.3390/ijms19010307. Int J Mol Sci. 2018. PMID: 29361687 Free PMC article.
Right- vs. Left-Sided Metastatic Colorectal Cancer: Differences in Tumor Biology and Bevacizumab Efficacy.
Ulivi P, Scarpi E, Chiadini E, Marisi G, Valgiusti M, Capelli L, Casadei Gardini A, Monti M, Ruscelli S, Frassineti GL, Calistri D, Amadori D, Passardi A. Ulivi P, et al. Among authors: passardi a. Int J Mol Sci. 2017 Jun 9;18(6):1240. doi: 10.3390/ijms18061240. Int J Mol Sci. 2017. PMID: 28598398 Free PMC article.
62 results
Jump to page
Feedback